Filing Details
- Accession Number:
- 0001209191-20-030709
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 19:13:11
- Reporting Period:
- 2020-05-18
- Accepted Time:
- 2020-05-19 19:13:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1397266 | K Matthew Fust | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-18 | 1,875 | $75.00 | 11,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.